An Open-Label, Multi-Site Phase 2 Study of the Safety and Feasibility of MDMA-Assisted Therapy for Eating Disorders: July 2020 Update
MAPS will conduct a Phase 2, open-label, multi-site study for MDMA as an adjunct to psychotherapy for anorexia nervosa restricting subtype (AN-R) and binge eating disorder (BED). This study will explore …